Kamada Plasma

Kamada Plasma LLC focuses on plasma-derived protein therapies for orphan indications and has a commercial product portfolio and a robust late-stage product pipeline. The company utilizes its proprietary platform technologies and techniques to extract and purify proteins from human plasma, producing highly purified liquid Alpha-1 Antitrypsin (AAT) and other plasma-derived immunoglobulins.Kamada Plasma is a wholly-owned subsidiary of Kamada.